Keywords: Radiomics, Analysis/Processing, Hyper-Fused Radiomics, Neoadjuvant Therapy, Breast Cancer
Motivation: Predicting pathologic complete response (pCR) to neoadjuvant therapy (NAT) in breast cancer (BC) is essential for personalized treatment planning.
Goal(s): This study aimed to enhance predictive accuracy of MRI-based radiomics by developing a hyper-fused radiomic model.
Approach: Hyper-fused radiomic features were extracted by combining voxel-wise data from multiple MRI parametric volumes, transformed into spherical coordinates for more comprehensive analysis.
Results: The hyper-fused model demonstrated higher predictive performance compared to conventional methods, with greater AUCs and robust associations with pCR, validated in an external test set.
Impact: This research highlights hyper-fused radiomics as a promising tool in precision oncology, potentially replacing contrast-based imaging for patients with contraindications and advancing predictive accuracy in therapy response.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords